Skip to content
Screener

Bruker BRKR Other operating expenses

Other operating expenses at other companies

908 Devices logo
908 DevicesMASS
$21.15M-1.8%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$132.05M+39.1%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
$39.74M+15.2%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1.44B+8.3%
Illumina logo
IlluminaILMN
$525M+9.1%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$8.14B+76.3%
Enterprise value$9.77B+40.5%
P/S2.3×+1.0×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development94.3100.2195.6197.3
Goodwill impairment charge134.9134.9
Other charges, net13.214.439.451.3
Total operating expenses481.3346.0850.9705.4
Operating (loss) income(65.3)11.9(55.1)43.7
Interest and other income (expense), net24.6(11.4)36.3(18.1)
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries(40.7)0.5(18.8)25.6
Income tax provision (benefit)14.2(3.1)16.75.6

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's other operating expenses?
Bruker (BRKR) reported other operating expenses of $481.3M in Q2 2026.
How has Bruker's other operating expenses changed year-over-year?
Bruker's other operating expenses increased by 39.1% year-over-year, from $346M to $481.3M.
What is the long-term trend for Bruker's other operating expenses?
Over 4 years (2021 to 2025), Bruker's other operating expenses has grown at a 17.3% compound annual growth rate (CAGR), from $796.3M to $1.51B.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Bruker's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude